SEP 4, 2026 · PHASE 2 TRIAL
Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance Status
ClinicalTrials.gov
This is a Phase 2 clinical trial registry record with no results posted; the study is currently recruiting and has not yet generated efficacy or safety data.
Reported
Planned enrollment57
Study phasePhase 2
Primary outcome measureOverall Survival Rate at 12 Months